A support group for women infected with hepatitis C as a result of receiving contaminated blood products will continue to receive interim payments pending the hearing of its action against the HSE over its funding, the High Court has heard.
Positive Action, which represents women who received the blood products from the Irish Blood Transfusion Board, claims its public funding will be removed unless it signs a generic agreement with the HSE.
The organisation, which got €558,000 in public funds last year, is challenging the HSE’s implementation of a decision last March requiring the group to enter into a standard service agreement used by the HSE for its relationships with non-statutory bodies.
The group claims the decision is in breach of fair procedures. It wants a declaration that it is entitled to continued implementation of the agreement it had for the last few years.